Sources of Systematic Error in DCE-MRI Estimation of Low-level Blood-brain Barrier Leakage
Overview
Authors
Affiliations
Purpose: Dynamic contrast-enhanced (DCE) -MRI with Patlak model analysis is increasingly used to quantify low-level blood-brain barrier (BBB) leakage in studies of pathophysiology. We aimed to investigate systematic errors due to physiological, experimental, and modeling factors influencing quantification of the permeability-surface area product PS and blood plasma volume v , and to propose modifications to reduce the errors so that subtle differences in BBB permeability can be accurately measured.
Methods: Simulations were performed to predict the effects of potential sources of systematic error on conventional PS and v quantification: restricted BBB water exchange, reduced cerebral blood flow, arterial input function (AIF) delay and error. The impact of targeted modifications to the acquisition and processing were evaluated, including: assumption of fast versus no BBB water exchange, bolus versus slow injection of contrast agent, exclusion of early data from model fitting and correction. The optimal protocol was applied in a cohort of recent mild ischaemic stroke patients.
Results: Simulation results demonstrated substantial systematic errors due to the factors investigated (absolute PS error ≤ 4.48 × 10 min ). However, these were reduced (≤0.56 × 10 min ) by applying modifications to the acquisition and processing pipeline. Processing modifications also had substantial effects on in-vivo normal-appearing white matter PS estimation (absolute change ≤ 0.45 × 10 min ).
Conclusion: Measuring subtle BBB leakage with DCE-MRI presents unique challenges and is affected by several confounds that should be considered when acquiring or interpreting such data. The evaluated modifications should improve accuracy in studies of neurodegenerative diseases involving subtle BBB breakdown.
Ohene Y, Morrey W, Powell E, Smethers K, Luka N, South K Npj Imaging. 2025; 3(1):8.
PMID: 40051735 PMC: 11879872. DOI: 10.1038/s44303-025-00071-5.
Cerebrovascular Function in Sporadic and Genetic Cerebral Small Vessel Disease.
Stringer M, Blair G, Kopczak A, Kerkhofs D, Thrippleton M, Chappell F Ann Neurol. 2024; 97(3):483-498.
PMID: 39552538 PMC: 11831873. DOI: 10.1002/ana.27136.
Varatharaj A, Jacob C, Darekar A, Yuen B, Cramer S, Larsson H Imaging Neurosci (Camb). 2024; 2:1-16.
PMID: 39449749 PMC: 11497077. DOI: 10.1162/imag_a_00324.
OHare N, Millican K, Ebong E Front Physiol. 2024; 15:1394725.
PMID: 39027900 PMC: 11254711. DOI: 10.3389/fphys.2024.1394725.
Vikner T, Garpebring A, Bjornfot C, Nyberg L, Malm J, Eklund A Sci Rep. 2024; 14(1):15338.
PMID: 38961135 PMC: 11222381. DOI: 10.1038/s41598-024-65944-y.